Sqi Diagnostics Inc (SQIDF) 0.2941 $SQIDF SQI

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Sqi Diagnostics Inc (SQIDF) 0.2941 $SQIDF

SQI Diagnostics Reports Third Quarter Financial Results
CNW Group - Tue Aug 18, 3:32PM CDT
Revenue Growth Continues
SQD.VN: 0.400 (-0.020)

SQI Diagnostics to Announce Third Quarter 2015 Results
CNW Group - Mon Aug 10, 3:37PM CDT
SQI Diagnostics Inc. ("SQI Diagnostics" or the "Company" (TSX-V: SQD; OTCQX: SQIDF), a life sciences company that develops and commercializes proprietary technologies and products for advanced microarray diagnostics, today announced that it plans to release its financial and operational results for the three and nine months ended June 30, 2015, after market close on Tuesday, August 18, 2015. President and CEO, Andrew Morris, along with Company management, will host a conference call on Wednesday August 19, 2015 at 10:00 a.m. ET to review financial results and discuss business developments for the period.
SQD.VN: 0.400 (-0.020)

SQI Diagnostics Reports Second Quarter Financial Results
PR Newswire - Thu May 21, 4:00PM CDT
First Platform Delivery to Global Pharma Customer
SQD.VN: 0.400 (-0.020)

SQI Diagnostics to Announce Second Quarter 2015 Results
CNW Group - Thu May 14, 3:30PM CDT
SQI Diagnostics Inc. ("SQI Diagnostics" or the "Company" (TSX-V: SQD; OTCQX: SQIDF), a life sciences company that develops and commercializes proprietary technologies and products for advanced microarray diagnostics, today announced that it plans to release its financial and operational results for the three and six months ended March 31, 2015, after market close on Thursday, May 21, 2015. President and CEO, Andrew Morris, along with Company management, will host a conference call on Friday May 22, 2015 at 10:00 a.m. ET to review financial results and discuss business developments for the period.
SQD.VN: 0.400 (-0.020)

SQI Diagnostics to Extend Warrant Expiry
PR Newswire - Fri Apr 17, 8:00AM CDT
SQI Diagnostics Inc. (TSX-V: SQD; OTCQX: SQIDF), a life sciences and diagnostics company that develops and commercializes proprietary technologies and products for advanced microarray diagnostics ("SQI", today announced that it has received approval from the TSX Venture Exchange to extend the expiry of 5,126,044 outstanding common share purchase warrants ("the Warrants" of the Company, which were issued in connection with the Company's May 2013 private placement financing.
SQD.VN: 0.400 (-0.020)

SQI Delivers Sqidlite System to Global Pharmaceutical Customer
CNW Group - Wed Apr 15, 8:00AM CDT
SQI Diagnostics Inc. (TSX-V: SQD; OTCQX: SQIDF), a life sciences and diagnostics company that develops and commercializes proprietary technologies and products for advanced microarray diagnostics ("SQI", today announced the delivery and installation of a sqidliteTM system under the terms of an agreement with a top tier global pharmaceutical customer. As previously disclosed, two custom immunogenicity assays have been successfully developed for this customer.
SQD.VN: 0.400 (-0.020)

Bristol-Myers Squibb to Highlight SQI's Technology at WRIB Conference
PR Newswire - Thu Apr 09, 8:00AM CDT
SQI's Strength in Immunogenicity Testing Featured In Multiple Presentations
O: 45.08 (+0.88), BMY: 59.22 (+0.47), SQD.VN: 0.400 (-0.020)

SQI Announces Election of Directors
CNW Group - Wed Apr 08, 1:32PM CDT
SQI Diagnostics Inc. ("SQI" or the "Company" (TSX-V: SQD; OTCQX: SQIDF), a life sciences company that develops and commercializes proprietary technologies and products for advanced microarray diagnostics, today announced the voting results for its nominees for director at its reconvened annual and special meeting of shareholders held today.
SQD.VN: 0.400 (-0.020)

SQI Diagnostics Inc. Announces Adjournment of Meeting
PR Newswire - Thu Mar 26, 12:10PM CDT
SQI Diagnostics Inc. ("SQI" or the "Company" (TSX-V: SQD; OTCQX: SQIDF) announced that after dealing with certain matters, including the appointment of auditors, its annual and special meeting of shareholders held on March 26, 2015 (the "Meeting" was adjourned, as previously disclosed on March 25, 2015, until April 8, 2015 at 11:00 a.m. (Toronto time). The date of the reconvened Meeting has been changed from that previous disclosed. The Meeting will reconvene at the offices of the Company's counsel, Gowling Lafleur Henderson LLP, located at 100 King Street West, Suite 1600, Toronto, Ontario.
SQD.VN: 0.400 (-0.020)

SQI Diagnostics Inc. Announces New Nominees to SQI Diagnostics Board and Adjournment of Meeting
PR Newswire - Wed Mar 25, 9:22PM CDT
SQI Diagnostics Inc. ("SQI" or the "Company" (TSX-V: SQD; OTCQX: SQIDF) announced that, as a result of recent discussions with certain shareholders representing approximately 45% of the outstanding voting common shares of the Company, after dealing with certain matters including the appointment of auditors at its annual and special meeting of shareholders on March 26, 2015 (the "Meeting" it intends to adjourn the Meeting such that the election of directors will take place when the Meeting reconvenes. The Meeting will be reconvened on April 7, 2015 at 11:00 a.m. (Toronto time) at the offices of the Company's counsel, Gowling Lafleur Henderson LLP, located at 100 King Street West, Suite 1600, Toronto, Ontario.
SQD.VN: 0.400 (-0.020)

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Wulcea Pioneers Safety in Smart Heated Apparel

Updated Category News Views 71

Tech Behind the Warmth and Safety You ever turn on a heated jacket and wonder if it'll keep you safe as much as warm? That's the scene with Wulcea, a brand diving headfirst into the smart heated clothing market. People are waking up to what’s inside these technological coats, not just how they feel on a frosty walk. It’s the kind of scenario where safety meets...

Continue Reading
ModelBest & OpenBMB Unveil Open-Source OCR Models

Updated Category News Views 112

A New Frontier in Document Parsing Just when you thought document parsing couldn't get any more advanced, ModelBest and OpenBMB come along with a game-changing release: the MiniCPM-OCR series. This duo of dynamite models, MiniCPM-OCR 1.0 and Jev, is all about taking the efficiency and performance expectations for open-source OCR models up a couple of notches. If you're an...

Continue Reading
HK Boosts Oversight of Building Repairs Post-Blaze

Updated Category News Views 144

Big Moves After a Tragic Fire Hong Kong's revamping its approach to building maintenance and oversight, clearly in reaction to the horrific Wang Fuk Court blaze last year. That fire didn't just leave scars; it blew open glaring gaps in the city's oversight of building repairs. The government's now jumping into action by launching a raft of measures aimed at preventing...

Continue Reading
MongoDB Faces Continued Legal Scrutiny Amid Growth Issues

Updated Category News Views 73

MongoDB's Legal Marmite: Sticky and Spreading Well, here we are, rolling up our sleeves with MongoDB, Inc. (NasdaqGM: MDB) in the spotlight again, not for some glorious tech breakthrough but a legal brouhaha. The whip of the market is as familiar as an old leather boot to traders like us. This time, we've got Kahn Swick & Foti, LLC (KSF), spearheaded by former Attorney...

Continue Reading
TCL Powers Senegal's Youth Olympics with Solar Display

Updated Category News Views 132

Innovative Display Tech Lands in Senegal Cutting through the noise of corporate clutter, TCL just made a move in Senegal that's got layers deeper than a PR stunt. They’ve handed over an ultra-low-power display system to the Université Amadou Mahtar Mbow (UAM) in Dakar, which is also moonlighting as the Youth Olympic Village for the 2026 Games. This isn't just any...

Continue Reading
Zhimeng Biopharma Hits Key Milestone in ALS Drug Trial

Updated Category News Views 156

Pivotal Point for Zhimeng's ALS Efforts Folks, get this—Zhimeng Biopharma's rolling out the big guns here with a significant step forward in their ALS treatment quest. This company just wrapped up patient enrollment for their next-gen ALS drug, CB03-154. We're talking about 255 patients now on board for a Phase 2/3 trial. The ground's shaking a bit because this...

Continue Reading
Main Street Merger Faces Scrutiny: What It Means for Shareholders

Updated Category News Views 51

Under the Radar, but Not for Long Ah, mergers—those grand gestures in corporate America that promise growth, synergy, and shareholder value. But not every deal is a head-turner; some fly under the radar until someone grabs the magnifying glass. And that's exactly what's happening with Main Street Financial Services Corp.'s (OTC: MSWV) proposed merger with First...

Continue Reading
Fashion and Philanthropy Unite at UBCF Kick-off Party

Updated Category News Views 65

Exclusivity and Dedication Mix at UBCF Event When fashion and philanthropy get together, you better believe it's more than just a pleasant evening. The Frederick Anderson Collection is hosting a swanky cocktail reception, kicking off the United Breast Cancer Foundation's (UBCF) highly-anticipated Think Pink Gala, and it's shaping up to be a unique affair wrapped in...

Continue Reading
Lawsuit Hits San Ramon Medical: Wages, Breaks in Dispute

Updated Category News Views 73

Legal Storm Unleashes on San Ramon Regional In the world of legal entanglements, San Ramon Regional Medical Center found itself on the receiving end of the latest workforce fuss. Allegations flying from a class action lawsuit claim the center's brass didn't hold up their end of the California Labor Code, particularly in providing legit meal breaks and rest periods. Now,...

Continue Reading
Chemours Class Action: Key Deadline Approaches Fast

Updated Category News Views 77

A Rocky Ride for Chemours Investors The ticker might read NYSE:CC, but right now, that might as well stand for "Caution, Cautious," if you ask me. Investors are on high alert with Chemours facing a class action lawsuit, and the stakes couldn’t be higher. Deadline's looming on December 7, 2026, for those gunning for lead plaintiff status. It's a tense time for anyone who...

Continue Reading

Top 5 Most Recently Viewed Articles

BD Prepares for Financial Results Release in November 2025

Updated Category News Views 201

BD to Present Financial Results for Fiscal Year 2025 BD (Becton, Dickinson and Company) (NYSE: BDX), a prominent player in the global medical technology landscape, is set to announce its financial results for the fourth quarter as well as the full year of fiscal 2025. This significant announcement will take place during an audio webcast scheduled for a future date,...

Continue Reading
Investing Smart: Discover Three Undervalued Tech Stocks

Updated Category News Views 194

Investing $5,000 might feel like a drop in the ocean when staring down the market’s towering ticket prices. Yet, here we are, with the average funded account on Robinhood sitting at about $5,773. Small retail investors still dip their toes in the water amidst a sea of high-priced shares. Platforms like Robinhood have revolutionized how individuals engage with stocks....

Continue Reading
Exciting Developments for Sokoman Minerals with New Offering

Updated Category News Views 207

Major Offering Announcement from Sokoman Minerals Corp. Sokoman Minerals Corp. is making waves with a new private placement worth $24 million, spearheaded by lead underwriter Canaccord Genuity Corp. This offering promises to be a significant step forward for the company, enhancing its financial strength and supporting its ambitious growth strategies. Details of the...

Continue Reading
Hudbay Enhances Ownership of Copper Mountain Mine Investment

Updated Category News Views 244

The Acquisition of Copper Mountain Mine Hudbay Minerals Inc. (“Hudbay” or the “company”) (TSX, NYSE: HBM) is excited to share its recent decision to secure 100% ownership of the Copper Mountain Mine through a strategic acquisition. This agreement with Mitsubishi Materials Corporation (MMC) allows Hudbay to not only fortify its foothold in the Canadian mining...

Continue Reading
Exploring the Expanding Horizon of the Methanol Market

Updated Category News Views 168

The Future of the Methanol Market The global methanol market is on a significant growth trajectory, with projections estimating it will reach approximately USD 55.80 billion by 2030. This growth is driven by a compound annual growth rate (CAGR) of 4.1% from current valuations, primarily fueled by various advancements in production technologies and increasing applications...

Continue Reading